C B Freeman

Author PubWeight™ 16.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia. Br Med J 1973 1.67
2 Lymphocyte reactivity in pregnancy. Br Med J 1972 1.21
3 Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. J Natl Cancer Inst 1980 1.15
4 Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts. Clin Exp Immunol 1973 1.08
5 Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions. Br J Cancer 1978 1.05
6 Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia. Br J Cancer 1976 0.97
7 Influence of HLA, ABO, and Rh(D) on survival after remission in acute myelogenous leukaemia. Lancet 1977 0.96
8 Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia. Br J Cancer 1980 0.94
9 Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis. Gut 1972 0.94
10 Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors. Br J Cancer 1973 0.90
11 Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst 1980 0.87
12 Response of remission lymphocytes to autochthonous leukaemic myeloblasts. Br J Cancer 1976 0.87
13 Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma. Clin Immunol Immunopathol 1982 0.80
14 Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin. J Natl Cancer Inst 1983 0.78
15 A new translocation associated with the Ph1 chromosome and an acute course of chronic granulocytic leukaemia. Br J Cancer 1975 0.75
16 Long survival in acute myelogenous leukaemia. Br Med J (Clin Res Ed) 1981 0.75
17 Receptors for human immunoglobulin on acute myeloid leukaemic leucocytes. Br J Cancer 1976 0.75
18 Proceedings: Active immunotherapy in acute myeloid leukaemia. Br J Cancer 1975 0.75
19 Induction of complement receptors in human cell lines derived from undifferentiated lymphomas. Lab Invest 1981 0.75
20 Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. Br J Cancer 1975 0.75
21 Proceedings: Surface immunological markers in acute myeloblastic leukaemia. Br J Cancer 1975 0.75